Loading clinical trials...
Loading clinical trials...
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Conditions
Interventions
Vonapanitase
Placebo
Locations
41
United States
University of Alabama at Birmingham
Birmingham, Alabama, United States
AKDHC Medical Research Services, LLC
Phoenix, Arizona, United States
Banner University Medical Center Tucson
Tucson, Arizona, United States
AKDHC Medical Research Services, LLc
Tucson, Arizona, United States
VA Loma Linda Healthcare System
Loma Linda, California, United States
VA Medical Center Long Beach
Long Beach, California, United States
Start Date
August 1, 2015
Primary Completion Date
February 1, 2018
Completion Date
May 1, 2019
Last Updated
August 13, 2019
NCT05398783
NCT07547098
NCT07232537
NCT05196035
NCT06721143
NCT06278207
Lead Sponsor
Proteon Therapeutics
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions